Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease: A Population-Based Danish Cohort Study
- 1 October 2020
- journal article
- editorial
- Published by Elsevier BV in Gastroenterology
- Vol. 159 (4), 1609-1611
- https://doi.org/10.1053/j.gastro.2020.06.030
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk Fonden (NNF16OC0022586)
This publication has 8 references indexed in Scilit:
- Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHANAlimentary Pharmacology & Therapeutics, 2018
- Methotrexate for the Treatment of Pediatric Crohn’s Disease: A Systematic Review and Meta-analysisInflammatory Bowel Diseases, 2018
- Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014BMJ, 2017
- Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel DiseaseGastroenterology, 2017
- Association Between Tumor Necrosis Factor-α Antagonists and Risk of Cancer in Patients With Inflammatory Bowel DiseasePublished by American Medical Association (AMA) ,2014
- Mortality and Cancer in Pediatric-Onset Inflammatory Bowel Disease: A Population-Based StudyThe American Journal of Gastroenterology, 2013
- Management of Pediatric Ulcerative ColitisJournal of Pediatric Gastroenterology and Nutrition, 2012
- Decreasing Risk of Colorectal Cancer in Patients With Inflammatory Bowel Disease Over 30 YearsGastroenterology, 2012